Recombinant multi-species CSN2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CSN2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is a member of the beta casein family. There are two types of casein protein, beta (encoded by this gene) and kappa, both of which are secreted in human milk. Beta casein is the principal protein in human milk and the primary source of essential amino acids for a suckling infant. Beta and kappa casein proteins acting together form spherical micelles which bind within them important dietary minerals, such as calcium and phosphorous. In addition, the C-terminal 14 aa of the protein has antimicrobial activity, especially in preterm milk, displaying antibacterial activity against S. aureus and Y. enterocolitica. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2020]
The Alternative Names of target: CSN2,Beta-casein,CASB,PDC213

Target products collectionGo to CSN2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0830-Ab-1/ GM-Tg-hg-SE0830-Ab-2 Human CSN2 protein Human
GM-Tg-rg-SE0830-Ab-1/ GM-Tg-rg-SE0830-Ab-2 Rat CSN2 protein Rat
GM-Tg-mg-SE0830-Ab-1/ GM-Tg-mg-SE0830-Ab-2 Mouse CSN2 protein Mouse
GM-Tg-cynog-SE0830-Ab-1/ GM-Tg-cynog-SE0830-Ab-2 Cynomolgus/Rhesus macaque CSN2 monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0830-Ab-1/ GM-Tg-felg-SE0830-Ab-2 Feline CSN2 protein Feline
GM-Tg-cang-SE0830-Ab-1/ GM-Tg-cang-SE0830-Ab-2 Canine CSN2 protein Canine
GM-Tg-bovg-SE0830-Ab-1/ GM-Tg-bovg-SE0830-Ab-2 Bovine CSN2 protein Bovine
GM-Tg-equg-SE0830-Ab-1/ GM-Tg-equg-SE0830-Ab-2 Equine CSN2 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0830-Ab-1/ GM-Tg-hg-SE0830-Ab-2; GM-Tg-rg-SE0830-Ab-1/ GM-Tg-rg-SE0830-Ab-2;
GM-Tg-mg-SE0830-Ab-1/ GM-Tg-mg-SE0830-Ab-2; GM-Tg-cynog-SE0830-Ab-1/ GM-Tg-cynog-SE0830-Ab-2;
GM-Tg-felg-SE0830-Ab-1/ GM-Tg-felg-SE0830-Ab-2; GM-Tg-cang-SE0830-Ab-1/ GM-Tg-cang-SE0830-Ab-2;
GM-Tg-bovg-SE0830-Ab-1/ GM-Tg-bovg-SE0830-Ab-2; GM-Tg-equg-SE0830-Ab-1/ GM-Tg-equg-SE0830-Ab-2
Products Name CSN2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CSN2
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CSN2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.